World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
29526
World Ranking
17397
National Ranking
8712

Overview

Vered Stearns is affiliated with Johns Hopkins University in the United States and has a significant body of research in the fields of Medicine, particularly focusing on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, and Genetics.

Stearns' research primarily addresses topics such as:

  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • Cancer Immunotherapy and Biomarkers
  • Estrogen and related hormone effects
  • HER2/EGFR in Cancer Research
  • Cancer Genomics and Diagnostics
  • Cancer survivorship and care

With a publication record featuring prominent journals, Stearns has frequently published in:

  • Cancer Research
  • Journal of Clinical Oncology
  • ONCOLOGY
  • Breast Cancer Research and Treatment
  • Annals of Oncology

Among recent notable papers authored or coauthored by Stearns are:

  • ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4), 2020, Annals of Oncology
  • Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials, 2022, Journal of Clinical Oncology
  • TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker, 2020, Annals of Oncology
  • Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach, 2020, JCO Oncology Practice
  • Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer, 2020, Frontiers in Physiology

Stearns has collaborated extensively with several researchers, including:

  • Antonio C. Wolff
  • Roisín M. Connolly
  • Karen L. Smith
  • Jennifer Y. Sheng
  • Amanda L. Blackford

Their scholarly contributions span clinical and molecular investigations, especially in breast cancer, exploring treatment efficacy, immunological markers, and cancer subtype-specific management strategies. The data indicates a sustained focus on both clinical outcomes and biomarker development in cancer research.

Best Publications

  • CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment

    Yan Jin;Zeruesenay Desta;Vered Stearns;Bryan Ward

  • American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

    Harold J. Burstein;Ann Alexis Prestrud;Jerome Seidenfeld;Holly Anderson

  • Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine

    Vered Stearns;Michael D. Johnson;James M. Rae;James M. Rae;Alan Morocho

  • Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

    Harold J. Burstein;Harold J. Burstein;Sarah Temin;Holly Anderson;Thomas A. Buchholz

  • Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update

    Manfred Kaufmann;Gabriel N. Hortobagyi;Aron Goldhirsch;Suzy Scholl

  • Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

    Olivia Pagani;Meredith M. Regan;Barbara A. Walley;Gini F. Fleming

  • Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

    Ayca Gucalp;Ayca Gucalp;Sara Tolaney;Steven J. Isakoff;James N. Ingle

  • Paroxetine controlled release in the treatment of menopausal hot flashes: A randomized, controlled trial

    Vered Stearns;Katherine L. Beebe;Malini Iyengar;Eric Dube

  • Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells.

    Hsing Chen Tsai;Huili Li;Leander Van Neste;Yi Cai

  • Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

    P. A. Francis;P. A. Francis;O. Pagani;G. F. Fleming;B. A. Walley

  • Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment.

    Silvana Borges;Zeruesenay Desta;Lang Li;Todd C Skaar

  • Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006

    M. Kaufmann;G. Von minckwitz;H. D. Bear;Aman U Buzdar

  • TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

    Steven J. Isakoff;Erica L. Mayer;Lei He;Tiffany A. Traina

  • Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers.

    Huili Li;Katherine B. Chiappinelli;Angela A. Guzzetta;Hariharan Easwaran

  • When Is a Tumor Marker Ready for Prime Time? A Case Study of c-erbB-2 as a Predictive Factor in Breast Cancer

    Hideko Yamauchi;Vered Stearns;Daniel F. Hayes

  • Detection of cancer DNA in plasma of patients with early-stage breast cancer.

    Julia A. Beaver;Danijela Jelovac;Sasidharan Balukrishna;Rory L. Cochran

  • Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer

    N. Lynn Henry;Faouzi Azzouz;Zereunesay Desta;Lang Li

  • Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood

    Michaela J Higgins;Danijela Jelovac;Evan Barnathan;Brian Blair

  • Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression

    Harold J. Burstein;Christina Lacchetti;Holly Anderson;Thomas A. Buchholz

  • Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update

    Harold J. Burstein;Christina Lacchetti;Holly Anderson;Thomas A. Buchholz

Frequent Co-Authors

Antonio C. Wolff
Antonio C. Wolff Johns Hopkins University
Daniel F. Hayes
Daniel F. Hayes University of Michigan–Ann Arbor
David A. Flockhart
David A. Flockhart Indiana University
Nancy E. Davidson
Nancy E. Davidson University of Washington
Saraswati Sukumar
Saraswati Sukumar Johns Hopkins University School of Medicine
Eric P. Winer
Eric P. Winer Yale University
Edward Gabrielson
Edward Gabrielson Johns Hopkins University School of Medicine
Lisa A. Carey
Lisa A. Carey University of North Carolina at Chapel Hill
Steffi Oesterreich
Steffi Oesterreich University of Pittsburgh
Elizabeth M. Jaffee
Elizabeth M. Jaffee Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always require medical school. There are many related online degree options that can open doors to rewarding healthcare roles. For instance, those interested in pharmaceuticals can consider online pharmacy school programs, which offer flexibility for working professionals.

Another growing field is health informatics. By earning a degree in health informatics, you can help manage patient data, medical records, and ensure compliance with healthcare regulations.

For those who prefer administrative roles, medical billing and coding online courses cost significantly less than traditional programs and lead to essential positions in healthcare administration.

If you're aiming for a more advanced clinical pathway, becoming a nurse practitioner may be ideal. The cheapest np school options online make this career goal more attainable.

Each of these online programs offers a unique entry point into the expanding field of medicine, providing both affordability and flexibility to suit diverse career ambitions.

Best Scientists Citing Vered Stearns

Trending Scientists

Recently Published Articles